BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Senesco Technologies, Inc. 

721 Route 202/206
Suite 130
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-864-4444 Fax: 908-864-4440


SEARCH JOBS










 Company News
Senesco Technologies, Inc. (SNT) Presents Company Update At 2014 Biotechnology Industry Organization (BIO) International Convention 6/26/2014 7:28:57 AM
Senesco Technologies, Inc. (SNT) Brings In A New CEO 6/25/2014 4:41:58 PM
Senesco Technologies, Inc. (SNT) To Update On R&D Plans At Biotechnology Industry Organization (BIO) 6/19/2014 8:25:00 AM
Senesco Technologies, Inc. (SNT) Announces Update On SNS01-T At American Society of Clinical Oncology 6/2/2014 11:10:33 AM
Senesco Technologies, Inc. (SNT) Completes Acquisition Of Fabrus, An Opko Health, Inc. Portfolio Company 5/20/2014 8:38:57 AM
Senesco Technologies, Inc. (SNT) Completes Acquisition Of Fabrus LLC 5/19/2014 9:57:04 AM
Senesco Technologies, Inc. (SNT) Reports Second Quarter Of Fiscal Year 2014 Financial Results 5/12/2014 6:57:36 AM
Senesco Technologies, Inc. (SNT) Announces Presentation On The Effectiveness Of eIF5A In Inhibiting Tumor Progression In Liver Cancer Models 4/28/2014 9:05:35 AM
Senesco Technologies, Inc. (SNT) Opens Two New Clinical Trial Sites And Initiates Treatment Of The First Patient In South Africa 3/12/2014 8:28:10 AM
In Non-clinical Cancer Studies Senesco Technologies, Inc. (SNT)’s Therapeutic Candidate, SNS01-T, Works Synergistically In Combination With The Active Components Of Revlimid® And Velcade® 3/4/2014 8:47:37 AM
12345678910...